Hyperconnectivity of two separate long-range cholinergic systems contributes to the reorganization of the brain functional connectivity during nicotine withdrawal in male mice.


Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
31 Mar 2023
Historique:
medline: 11 4 2023
entrez: 10 4 2023
pubmed: 11 4 2023
Statut: epublish

Résumé

Chronic nicotine results in dependence with withdrawal symptoms upon discontinuation of use, through desensitization of nicotinic acetylcholine receptors and altered cholinergic neurotransmission. Nicotine withdrawal is associated with increased whole-brain functional connectivity and decreased network modularity, however, the role of cholinergic neurons in those changes is unknown. To identify the contribution of nicotinic receptors and cholinergic regions to changes in the functional network, we analyzed the contribution of the main cholinergic regions to brain-wide activation of the immediate early-gene FOS during withdrawal in male mice and correlated these changes with the expression of nicotinic receptor mRNA throughout the brain. We show that the main functional connectivity modules included the main long-range cholinergic regions, which were highly synchronized with the rest of the brain. However, despite this hyperconnectivity they were organized into two anticorrelated networks that were separated into basal forebrain projecting and brainstem-thalamic projecting cholinergic regions, validating a long-standing hypothesis of the organization of the brain cholinergic systems. Moreover, baseline (without nicotine) expression of Discontinuation of nicotine use in dependent users is associated with increased whole-brain activation and functional connectivity and leads to withdrawal symptoms. Here we investigated the contribution of the nicotinic cholinergic receptors and main cholinergic projecting brain areas in the whole-brain changes associated with withdrawal. This not only allowed us to visualize and confirm the previously described duality of the cholinergic brain system using this novel methodology, but also identify nicotinic receptors together with 1751 other genes that contribute, and could thus be targets for treatments against, nicotine withdrawal and dependence.

Identifiants

pubmed: 37034602
doi: 10.1101/2023.03.29.534836
pmc: PMC10081261
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIDA NIH HHS
ID : F30 DA059437
Pays : United States

Commentaires et corrections

Type : UpdateIn

Références

ACS Chem Neurosci. 2023 Feb 1;14(3):468-480
pubmed: 36630309
Cold Spring Harb Perspect Med. 2013 Jun 01;3(6):
pubmed: 23732855
Psychopharmacology (Berl). 2012 May;221(2):317-27
pubmed: 22147259
Handb Exp Pharmacol. 2020;258:373-393
pubmed: 31267166
Nat Neurosci. 2010 Sep;13(9):1128-36
pubmed: 20711186
Brain Res. 1987 Jun 16;413(2):229-50
pubmed: 3300852
Appl Environ Microbiol. 2019 May 16;85(11):
pubmed: 30926728
Neuroscience. 1988 Oct;27(1):1-39
pubmed: 3059226
Cell. 2016 Jun 16;165(7):1789-1802
pubmed: 27238021
Addict Biol. 2014 Sep;19(5):791-9
pubmed: 23448145
J Neurochem. 1988 Apr;50(4):1243-7
pubmed: 3346676
J Neurosci. 1995 Dec;15(12):8353-61
pubmed: 8613768
Mol Cell Neurosci. 2009 Jul;41(3):337-47
pubmed: 19409493
Front Synaptic Neurosci. 2013 Jul 30;5:2
pubmed: 23908628
Neuropsychopharmacology. 2013 Nov;38(12):2363-72
pubmed: 23708507
Front Mol Neurosci. 2021 Mar 31;14:654031
pubmed: 33867936
Nicotine Tob Res. 2015 Nov;17(11):1311-7
pubmed: 25646348
Aging (Albany NY). 2015 Dec;7(12):1028-9
pubmed: 26684501
Gen Hosp Psychiatry. 2012 Nov-Dec;34(6):702.e9-702.e11
pubmed: 22325630
J Comp Neurol. 1983 Feb 20;214(2):170-97
pubmed: 6841683
Sci Rep. 2017 Jul 21;7(1):6137
pubmed: 28733588
Neurosci Biobehav Rev. 2010 Nov;35(2):232-47
pubmed: 20493211
Neuron. 2020 May 6;106(3):369-387
pubmed: 32380050
Nucleic Acids Res. 2005 Jan 1;33(Database issue):D428-32
pubmed: 15608231
J Biol Chem. 2002 Nov 22;277(47):44920-4
pubmed: 12244045
Neuropharmacology. 2016 Aug;107:294-304
pubmed: 27020042
Cell Tissue Res. 2018 Sep;373(3):565-575
pubmed: 29250747
Addict Biol. 2015 Mar;20(2):407-14
pubmed: 24529072
Am J Med Genet B Neuropsychiatr Genet. 2009 Oct 5;150B(7):950-9
pubmed: 19180564
J Natl Cancer Inst. 2008 Nov 5;100(21):1552-6
pubmed: 18957677
Nature. 2007 Jan 11;445(7124):168-76
pubmed: 17151600
Learn Mem. 2016 Jul 15;23(8):405-14
pubmed: 27421892
Ann N Y Acad Sci. 2015 Sep;1349:64-82
pubmed: 26348486
Brain Sci. 2013 Feb 15;3(1):159-76
pubmed: 24961312
Int J Dev Neurosci. 2017 May;58:9-16
pubmed: 28153524
Behav Brain Res. 2017 Jul 14;330:118-126
pubmed: 28506623
Neuron. 2017 Apr 19;94(2):363-374.e4
pubmed: 28426969
Psychopharmacology (Berl). 2021 Aug;238(8):2313-2324
pubmed: 33932163
Neuropsychopharmacology. 2020 Oct;45(11):1920-1930
pubmed: 32559759
Nat Rev Neurosci. 2010 Jun;11(6):389-401
pubmed: 20485364
Behav Pharmacol. 1999 Nov;10(6-7):587-96
pubmed: 10780500
Science. 1996 Sep 6;273(5280):1399-402
pubmed: 8703077
Mol Pharmacol. 2013 Apr;83(4):753-8
pubmed: 23247824
Biol Psychiatry. 2023 Feb 1;:
pubmed: 36736419
Pharmacol Biochem Behav. 2008 Sep;90(3):409-15
pubmed: 18466962
Am J Med Genet B Neuropsychiatr Genet. 2016 Dec;171(8):1057-1071
pubmed: 27473937
J Neurosci. 2016 Aug 17;36(33):8612-23
pubmed: 27535909
Physiol Behav. 2013 Jul 2;119:103-9
pubmed: 23769693
Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7965-70
pubmed: 12802017
Psychopharmacology (Berl). 2006 Jun;186(3):402-13
pubmed: 16416333
Eur J Neurosci. 2019 Aug;50(3):2247-2254
pubmed: 29802666
Psychopharmacology (Berl). 2001 Aug;157(1):105-10
pubmed: 11512050
Elife. 2019 Jan 08;8:
pubmed: 30616717
Neuron. 1996 May;16(5):905-8
pubmed: 8630247
PLoS One. 2014 Feb 05;9(2):e88228
pubmed: 24505440
Prog Neurobiol. 1991;37(6):475-524
pubmed: 1763188
PLoS Comput Biol. 2013;9(1):e1002853
pubmed: 23300432
J Neurosci. 2014 Mar 19;34(12):4285-92
pubmed: 24647948
Neuropsychopharmacology. 2022 Feb;47(3):641-651
pubmed: 34326477
Synapse. 2010 Oct;64(10):754-64
pubmed: 20336623
Anat Embryol (Berl). 1991;184(3):275-90
pubmed: 1724358
Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3159-68
pubmed: 18640919
Mol Neurobiol. 2022 May;59(5):3280-3293
pubmed: 35297011
Nat Genet. 1999 Oct;23(2):185-8
pubmed: 10508514
Cell Stem Cell. 2007 Nov;1(5):515-28
pubmed: 18371391
Neuroimage. 2010 Sep;52(3):1059-69
pubmed: 19819337
Eur J Neurosci. 2019 Mar;49(5):604-622
pubmed: 29797362
Brain Sci. 2021 Jan 29;11(2):
pubmed: 33573081
Nicotine Tob Res. 2019 Feb 18;21(3):377-382
pubmed: 30137439
Pharmacol Ther. 1996;72(1):51-81
pubmed: 8981571
J Neurobiol. 2002 Dec;53(4):590-605
pubmed: 12436423
Neuropharmacology. 2014 Feb;77:217-23
pubmed: 24107576
Biochem Pharmacol. 2009 Oct 1;78(7):756-65
pubmed: 19540212
Nat Commun. 2021 Aug 25;12(1):5121
pubmed: 34433818
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4689-4695
pubmed: 30782826
Nat Neurosci. 2010 Sep;13(9):1120-7
pubmed: 20711185
Trends Pharmacol Sci. 2017 Feb;38(2):169-180
pubmed: 27890353
Proc Natl Acad Sci U S A. 2020 Jan 28;117(4):2149-2159
pubmed: 31937658
J Neurochem. 2021 Jun;157(5):1652-1673
pubmed: 33742685
Behav Brain Res. 2016 Nov 1;314:226-33
pubmed: 27491589
Ann N Y Acad Sci. 2015 Sep;1349:1-45
pubmed: 25876458
Neuron. 2017 Apr 5;94(1):7-18
pubmed: 28384477
Curr Top Behav Neurosci. 2015;23:103-35
pubmed: 25655889
Brain Res Bull. 2018 Apr;138:56-63
pubmed: 28528203
eNeuro. 2021 Nov 4;8(6):
pubmed: 34580158
Nicotine Tob Res. 2008 Jan;10(1):35-45
pubmed: 18188743
Arch Gen Psychiatry. 2009 Apr;66(4):431-41
pubmed: 19349313
Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1435-40
pubmed: 26772314
Eur Neuropsychopharmacol. 2016 Sep;26(9):1378-1389
pubmed: 27461514
Nature. 2010 Nov 11;468(7321):263-9
pubmed: 21068835
Handb Exp Pharmacol. 2009;(192):335-67
pubmed: 19184655
Cell Res. 2016 Jun;26(6):728-42
pubmed: 27103432
Nat Neurosci. 2014 Dec;17(12):1751-8
pubmed: 25402857
Nat Genet. 2010 May;42(5):436-40
pubmed: 20418889
Dev Neurosci. 2014;36(3-4):347-55
pubmed: 24854235
Mol Cell Neurosci. 2002 Dec;21(4):616-25
pubmed: 12504594
Cell. 2014 Nov 6;159(4):896-910
pubmed: 25417164
Nat Commun. 2020 Oct 20;11(1):5302
pubmed: 33082346
Neuroscience. 2001;106(1):129-36
pubmed: 11564423
J Neurosci Res. 2015 Apr;93(4):660-5
pubmed: 25430056
Genes Brain Behav. 2010 Oct;9(7):741-50
pubmed: 20584212
Pharmacol Biochem Behav. 2018 Aug;171:54-65
pubmed: 29908200
Addict Behav. 2009 Apr;34(4):365-73
pubmed: 19097706
J Neurophysiol. 1999 Aug;82(2):978-98
pubmed: 10444692
Nat Genet. 2019 Feb;51(2):237-244
pubmed: 30643251

Auteurs

Lieselot L G Carrette (LLG)

Department of Psychiatry, UC San Diego, La Jolla, CA, 92032, United States.

Adam Kimbrough (A)

Department of Psychiatry, UC San Diego, La Jolla, CA, 92032, United States.

Pasha A Davoudian (PA)

Medical Scientist Training Program, Yale University School of Medicine, New Haven, CT, 06511, United States.
Interdepartmental Neuroscience Program, Yale University School of Medicine, New Haven, CT, 06511, United States.

Alex C Kwan (AC)

Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, United States.

Andres Collazo (A)

Beckman Institute, CalTech, Pasadena, CA, 91125, United States.

Olivier George (O)

Department of Psychiatry, UC San Diego, La Jolla, CA, 92032, United States.

Classifications MeSH